Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Clinical Nephrology|September 11, 2004
Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney diseaseM H Schwenk, D A BlausteinAdvances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1994
The pharmacokinetics of acetazolamide during CAPDM H Schwenk, D A Blaustein, J D WagnerThe Journal of Rheumatology|April 29, 1998
Antinuclear antibody negative systemic lupus erythematosus presenting as bilateral facial paralysisD A Blaustein, S A BlausteinDICP : the Annals of Pharmacotherapy|July 1, 1989
Recombinant human erythropoietinM H Schwenk, C E HalstensonEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Misleading acute hypercalcemia due to hyperlipidemia: a method-dependent errorI Sachmechi, G Shah, L Rezainadimi, et al.Biopharmaceutics & Drug Disposition|September 16, 1998
Blood disposition and urinary excretion kinetics of methazolamide following oral administration to human subjectsD R Taft, S Nordt, G R Iyer, et al.Pharmacotherapy|July 1, 1995
Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysisM H Schwenk, W L St Peter, M G Meese, et al.Journal of Clinical Pharmacology|July 1, 1994
The effect of sucralfate on serum lipids and lipoproteins in normal volunteers [corrected]M H Schwenk, S I Berk, D V Morgan, et al.American Journal of Nephrology|December 10, 1998
Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patientsC Charytan, A Goldfarb-Rumyantzev, Y F Wang, et al.Pageof 2